Neurogene Inc. NGNE

28.31 (2.94) (9.41%) as of 25 Sep
Market cap
$625.4M
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
269.01 312.41 197.16 82.02 142.47 192.56 143.09 76.93 108.09 103.06
Receivables
— — — — — — 0.50 0.24 0.74 0.43
Other current assets
2.76 3.52 3.19 2.70 1.52 1.97 0.50 0.24 0.74 0.43
Total current assets
271.77 315.92 200.35 84.72 143.99 194.52 143.60 77.17 108.83 103.49
Property, Plant, Equpment (Net)
12.79 15.42 17.17 20.12 6.45 3.57 2.06 0.40 0.91 0.85
Long-Term Investments
— — — 0.88 0.88 — — — — 50.05
Goodwill and Intangible Assets (Total)
— — — — 0.13 0.35 0.57 — — —
Long-term assets (Other)
1.37 1.31 1.27 0.94 1.93 1.93 0.03 0.05 0.60 —
Total non-current assets
16.83 19.81 22.23 24.55 19.27 16.00 3.43 0.45 1.50 50.90
Total Assets
288.60 335.73 222.57 109.27 163.26 210.52 147.02 77.62 110.33 154.38
Accounts Payable
1.95 1.34 2.60 0.63 7.42 7.18 4.13 4.62 10.96 9.52
Accrued Expenses
10.76 9.73 17.50 5.32 — — — — — —
Current Part of Capital Lease
0.01 0.05 0.04 0.02 0.06 0.05 0.06 0.01 — —
Total current liabilities
16.41 15.16 22.97 6.65 8.64 7.89 4.74 4.63 10.96 9.52
Long Term Debt (Total)
0.01 0.03 0.07 0.07 0.07 0.11 0.15 0.01 0.03 0.05
Non-current Revenue (Deferred)
— — — — — — 0.00 0.31 0.45 0.15
Non-current Liabilities (Other)
0.05 0.05 0.20 — — 0.00 — 0.32 0.49 0.20
Total non-current liabilities
7.31 10.20 13.58 3.99 11.76 11.41 0.59 0.32 0.49 0.20
Total liabilities
23.72 25.36 36.55 10.64 20.40 19.30 5.34 4.95 11.44 9.72
Additional Paid In Capital
617.54 572.67 373.18 5.10 536.36 524.02 441.22 302.76 297.46 293.11
Preferred Stock (Total)
— — — 244.37 — — — — — —
Retained Earnings
(352.65) (262.30) (187.15) (150.84) (393.50) (332.81) (299.53) (230.09) (198.50) (148.28)
Common Equity (Total)
264.89 310.38 186.02 (145.74) 142.86 191.22 141.69 72.67 98.89 144.66
Shareholders Equity (Total)
264.89 310.38 186.02 98.63 142.86 191.22 141.69 72.67 98.89 144.66
Shareholders Equity and Liabilities (Total)
288.60 335.73 222.57 109.27 163.26 210.52 147.02 77.62 110.33 154.38
Shares (Common)
15.49 14.86 12.82 0.43 2.12 2.11 1.90 1.18 1.17 1.17
Shares (Preferred)
— — — 106.30 — — — — — —
Shareholders Equity (Tangible)
264.89 310.38 186.02 98.63 142.74 190.87 141.12 72.67 98.89 144.66
Net Debt
(269.01) (312.38) (197.09) (81.95) (142.40) (192.45) (142.95) (76.92) (108.05) (103.01)
Total Debt
0.01 0.03 0.07 0.07 0.07 0.11 0.15 0.01 0.03 0.05

Fold the line items

In millions of $ except per-share values · columns are period end dates